Tianjin International Biopharmaceutical Industry Expo 2024

The biopharmaceutical industry, recognized as one of China’s strategic emerging industries, is a key area for modern medical transformation and is often regarded as an everlasting sunrise industry. As a focus area of the “14th Five-Year Plan” and the 2035 Vision, the biopharmaceutical industry in China is projected to grow significantly, with market size expected to exceed 10 trillion RMB by 2035. The BIOME 2024 China (Tianjin) International Biopharmaceutical Industry Expo aims to accelerate the development and innovation of the biopharmaceutical industry, fostering collaboration and enhancing brand recognition. The expo will bring together leading domestic and international brands from the biopharmaceutical industry, featuring over 20 forums and discussions on a wide range of topics. This event will provide a comprehensive platform for showcasing new products, setting trends, facilitating precise business matching, and offering immersive experiences, thus playing a pivotal role in driving the high-quality development of the biopharmaceutical industry and advancing China towards becoming a global biopharmaceutical powerhouse.

Range of Exhibition

The exhibition will cover a wide array of topics, including biopharmaceutical products and achievements, showcasing the latest developments in protein drugs, peptides, enzymes, biological preparations, antibody drugs, stem cell therapy, gene therapy, tumor immunotherapy, microbiology, molecular biology, and biochip services. It will also feature innovative medical devices such as medical imaging, in vitro diagnostics, surgical instruments, and smart healthcare technologies. Additionally, the expo will highlight biopharmaceutical ingredients including active pharmaceutical ingredients, natural extracts, and various biotechnological components. The chemical pharmaceutical sector will display chemical reagents, antibiotics, and other essential pharmaceutical materials. The event will also focus on biopharmaceutical technologies, packaging solutions, laboratory equipment, and talent exchange opportunities, providing a comprehensive view of the industry’s advancements and future trends.

Target Audience

Biopharmaceutical companies, healthcare professionals, medical device manufacturers, biotechnology researchers, pharmaceutical investors, healthcare policy makers, clinical researchers, regulatory consultants, pharmaceutical supply chain managers, academic institutions